Mettler-Toledo International Inc.
NYSE:MTDMedical - Diagnostics & Research
+$16.60 today
- Market cap
- $34.55B
- Beta
- 1.26
- P/E (TTM)
- 26.6
- EPS (TTM)
- $43.14
Volume 0.16M
Average 0.19M
MTD Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Mettler-Toledo International Inc.NYSE: MTD
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows in line with its trailing trend
Q2 FY2026 depreciation & amortization of $32.73M rose 7.5% year over year, in line with the +7.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 0.1% from the prior quarter. Over 3 fiscal years it compounded at +3.6% a year.
Context
- Depreciation & amortization amounted to 3.1% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +7.5% holds above the trailing-twelve-month pace of +7.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 125.61M USD
- Year-over-year change
- +1.9%
- 4-year CAGR
- +3.8%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 125.61M | +1.9% |
| FY2024 | 2024-12-31 | 123.22M | +1.7% |
| FY2023 | 2023-12-31 | 121.16M | +7.2% |
| FY2022 | 2022-12-31 | 113.02M | +4.6% |
| FY2021 | 2021-12-31 | 108.06M | — |
Depreciation & Amortization vs competitors
How MTD compares with its peers on the latest reported figures
- MTD's LTM Jun 2026 depreciation & amortization of $131M is the 9th largest of the 10 companies compared; the peer median is $342.2M.
- Its year-over-year change of +7.3% is the 6th highest of 10, against a peer median of +8.8%.
- Depreciation & amortization amounts to 3.2% of revenue for MTD, versus a peer median of 6.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.11B | +11.2% | -6.3% | 6.6% | |
| LTM Sep 2026 | $1.91B | -21.1% | +4.7% | 7.5% | |
| LTM Jul 2026 | $613.22M | +211.1% | +16.5% | 13.2% | |
| LTM Jul 2026 | $412.24M | -0.2% | -1.7% | 14.2% | |
| LTM Sep 2026 | $342.2M | +4.0% | +0.4% | 5.2% | |
| LTM Jul 2026 | $271M | -5.2% | -3.1% | 3.7% | |
| LTM Jun 2026 | $230.1M | +9.4% | +35.4% | 6.6% | |
| LTM Jun 2026 | $212.7M | +8.8% | +19.9% | 5.9% | |
| LTM Jun 2026 | $131M | +7.3% | +3.6% | 3.2% | |
| LTM Oct 2026 | $73.33M | +23.8% | +5.2% | 6.7% | |
| Peer median (excluding MTD) | $342.2M | +8.8% | +4.7% | 6.6% | |
Competitors are the stored peer set for MTD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 768.99M | 872.5M | 788.78M | 863.14M | 869.19M |
| Depreciation & Amortization | 108.06M | 113.02M | 121.16M | 123.22M | 125.61M |
| Deferred Income Tax | 563K | 26.52M | (13.37M) | (28.2M) | 3.79M |
| Stock-Based Compensation | 19.6M | 19.66M | 17.93M | 19.98M | 22.51M |
| Change in Working Capital | 4.4M | (172.64M) | 51.38M | (9.8M) | (65.33M) |
| Accounts Receivables | (66.47M) | (83.42M) | 50.3M | (53M) | (46.35M) |
| Inventory | (118.72M) | (43.39M) | 71.02M | 24.13M | (7.65M) |
| Accounts Payables | 93.97M | (13.83M) | (40.55M) | 12.08M | 33.76M |
| Other Working Capital | 95.61M | (32M) | (29.39M) | 6.99M | (45.09M) |
| Other Non-Cash Items | 7.23M | 0 | 0 | 0 | 0 |
| Operating Cash Flow | 908.83M | 859.07M | 965.87M | 968.35M | 955.77M |
| Capital Expenditures | (107.58M) | (121.24M) | (105.32M) | (103.9M) | (107.12M) |
| Acquisitions (Net) | (220.86M) | (37.95M) | (5.81M) | (10.09M) | (93.84M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 14.33M | 19.8M | (20.56M) | (5.47M) | 7.09M |
| Investing Cash Flow | (314.11M) | (139.4M) | (131.69M) | (119.46M) | (193.87M) |
| Debt Repayment | 391.97M | 359.86M | 29.77M | (18.73M) | 21.46M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 32.27M |
| Common Stock Repurchased | (1,000M) | (1.1B) | (900M) | (850M) | (800M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 17.48M | 24.1M | 10.64M | 12.75M | (8.91M) |
| Financing Cash Flow | (590.55M) | (716.04M) | (859.59M) | (855.98M) | (755.17M) |
| Effect of Forex Changes | 142K | (6.23M) | (754K) | (3.35M) | 801K |
| Net Change in Cash | 4.31M | (2.6M) | (26.16M) | (10.45M) | 7.53M |
| Free Cash Flow | 801.25M | 737.83M | 860.55M | 864.45M | 848.65M |
Mettler-Toledo International Inc.
NYSE:MTD
Intrinsic Alpha fair value
Locked
Current Price
$1,737.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.